MoonLake Immunotherapeutics (MLTX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $119.95M | +388.8% |
| 2024 | $24.54M | +88.1% |
| 2023 | $13.05M | +61.6% |
| 2022 | $8.08M | -62.1% |
| 2021 | $21.33M | +413.9% |
| 2020 | $4.15M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $119.95M | +388.8% |
| 2024 | $24.54M | +88.1% |
| 2023 | $13.05M | +61.6% |
| 2022 | $8.08M | -62.1% |
| 2021 | $21.33M | +413.9% |
| 2020 | $4.15M | — |